108 related articles for article (PubMed ID: 8575689)
1. Epidermal growth factor and transforming growth factor-beta in uterine fibroids and myometrium.
Vollenhoven BJ; Herington AC; Healy DL
Gynecol Obstet Invest; 1995; 40(2):120-4. PubMed ID: 8575689
[TBL] [Abstract][Full Text] [Related]
2. Expression, menstrual cycle-dependent activation, and bimodal mitogenic effect of transforming growth factor-beta1 in human myometrium and leiomyoma.
Arici A; Sozen I
Am J Obstet Gynecol; 2003 Jan; 188(1):76-83. PubMed ID: 12548199
[TBL] [Abstract][Full Text] [Related]
3. Quantification of messenger ribonucleic acid for epidermal growth factor in human myometrium and leiomyomata using reverse transcriptase polymerase chain reaction.
Harrison-Woolrych ML; Charnock-Jones DS; Smith SK
J Clin Endocrinol Metab; 1994 May; 78(5):1179-84. PubMed ID: 8175976
[TBL] [Abstract][Full Text] [Related]
4. Messenger ribonucleic acid expression of the insulin-like growth factors and their binding proteins in uterine fibroids and myometrium.
Vollenhoven BJ; Herington AC; Healy DL
J Clin Endocrinol Metab; 1993 May; 76(5):1106-10. PubMed ID: 7684390
[TBL] [Abstract][Full Text] [Related]
5. Presence of messenger ribonucleic acid for epidermal growth factor (EGF) and EGF receptor demonstrable in monolayer cell cultures of myometria and leiomyomata.
Yeh J; Rein M; Nowak R
Fertil Steril; 1991 Nov; 56(5):997-1000. PubMed ID: 1936340
[TBL] [Abstract][Full Text] [Related]
6. Steroid receptor binding and messenger RNA expression in fibroids from untreated and gonadotrophin-releasing hormone agonist pretreated women.
Vollenhoven BJ; Pearce P; Herington AC; Healy DL
Clin Endocrinol (Oxf); 1994 Apr; 40(4):537-44. PubMed ID: 8187322
[TBL] [Abstract][Full Text] [Related]
7. Up-regulation by progesterone of proliferating cell nuclear antigen and epidermal growth factor expression in human uterine leiomyoma.
Shimomura Y; Matsuo H; Samoto T; Maruo T
J Clin Endocrinol Metab; 1998 Jun; 83(6):2192-8. PubMed ID: 9626159
[TBL] [Abstract][Full Text] [Related]
8. Distribution of the A and B forms of the progesterone receptor messenger ribonucleic acid and protein in uterine leiomyomata and adjacent myometrium.
Viville B; Charnock-Jones DS; Sharkey AM; Wetzka B; Smith SK
Hum Reprod; 1997 Apr; 12(4):815-22. PubMed ID: 9159448
[TBL] [Abstract][Full Text] [Related]
9. [Epidermal growth factor (EGF) in uterine leiomyoma during tumour growth].
Wolańska M; Jaworski S
Ginekol Pol; 2005 Aug; 76(8):643-7. PubMed ID: 16363371
[TBL] [Abstract][Full Text] [Related]
10. Human leiomyoma smooth muscle cells show increased expression of transforming growth factor-beta 3 (TGF beta 3) and altered responses to the antiproliferative effects of TGF beta.
Lee BS; Nowak RA
J Clin Endocrinol Metab; 2001 Feb; 86(2):913-20. PubMed ID: 11158066
[TBL] [Abstract][Full Text] [Related]
11. [The estimation of LHRH receptors in the tissue of human leiomyoma, myometrium and endometrium].
Marinaccio M; Reshkin S; Pinto V; Paradiso A
Minerva Ginecol; 1994 Oct; 46(10):519-26. PubMed ID: 7838406
[TBL] [Abstract][Full Text] [Related]
12. Suppression of transforming growth factor-beta (TGF beta) and TGF beta receptor messenger ribonucleic acid and protein expression in leiomyomata in women receiving gonadotropin-releasing hormone agonist therapy.
Dou Q; Zhao Y; Tarnuzzer RW; Rong H; Williams RS; Schultz GS; Chegini N
J Clin Endocrinol Metab; 1996 Sep; 81(9):3222-30. PubMed ID: 8784073
[TBL] [Abstract][Full Text] [Related]
13. Localization and quantification of vascular endothelial growth factor messenger ribonucleic acid in human myometrium and leiomyomata.
Harrison-Woolrych ML; Sharkey AM; Charnock-Jones DS; Smith SK
J Clin Endocrinol Metab; 1995 Jun; 80(6):1853-8. PubMed ID: 7775632
[TBL] [Abstract][Full Text] [Related]
14. Interleukin 8 production and interleukin 8 receptor expression in human myometrium and leiomyoma.
Senturk LM; Sozen I; Gutierrez L; Arici A
Am J Obstet Gynecol; 2001 Mar; 184(4):559-66. PubMed ID: 11262453
[TBL] [Abstract][Full Text] [Related]
15. Type 2 angiotensin II receptor is expressed in human myometrium and uterine leiomyoma and is down-regulated during pregnancy.
Matsumoto T; Sagawa N; Mukoyama M; Tanaka I; Itoh H; Goto M; Itoh H; Horiuchi M; Dzau VJ; Mori T; Nakao K
J Clin Endocrinol Metab; 1996 Dec; 81(12):4366-72. PubMed ID: 8954043
[TBL] [Abstract][Full Text] [Related]
16. C-Met expression pattern in uterine leiomyoma.
Boynukalin FK; Comunoglu C; Türkmen I; Kuzey GM; Güler OT; Baykal C
Clin Exp Obstet Gynecol; 2014; 41(3):254-7. PubMed ID: 24992771
[TBL] [Abstract][Full Text] [Related]
17. Thrombospondin-1 and thrombospondin-2 mRNA and TSP-1 and TSP-2 protein expression in uterine fibroids and correlation to the genes COL1A1 and COL3A1 and to the collagen cross-link hydroxyproline.
Behera MA; Feng L; Yonish B; Catherino W; Jung SH; Leppert P
Reprod Sci; 2007 Dec; 14(8 Suppl):63-76. PubMed ID: 18089612
[TBL] [Abstract][Full Text] [Related]
18. Retinoic acid pathway genes show significantly altered expression in uterine fibroids when compared with normal myometrium.
Zaitseva M; Vollenhoven BJ; Rogers PA
Mol Hum Reprod; 2007 Aug; 13(8):577-85. PubMed ID: 17553814
[TBL] [Abstract][Full Text] [Related]
19. Reduced expression of 14-3-3 gamma in uterine leiomyoma as identified by proteomics.
Lv J; Zhu X; Dong K; Lin Y; Hu Y; Zhu C
Fertil Steril; 2008 Nov; 90(5):1892-8. PubMed ID: 18054924
[TBL] [Abstract][Full Text] [Related]
20. The management of uterine leiomyomas.
Vilos GA; Allaire C; Laberge PY; Leyland N;
J Obstet Gynaecol Can; 2015 Feb; 37(2):157-178. PubMed ID: 25767949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
